Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adaptation of the Transition Readiness Assessment Questionnaire for Pediatric-Onset Multiple Sclerosis: Protocol for a User-Centered Design Approach.

JMIR research protocols·2026

Same author

3-in-one <sup>PD-1</sup>CAR Tregs: A bioengineered cellular therapy for target engagement, activation, and immunosuppression with reparative potential.

iScience·2025

Same author

Medicare Part D Use and Costs for Immune-Mediated Neurologic Therapies.

JAMA network open·2025

Same author

Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years.

Neurology·2025

Same author

Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD.

Journal of neuroimmunology·2025

Same author

Epigenetic Aging in Pediatric-Onset Multiple Sclerosis.

Neurology·2025

Search research articles

Related Experiment Video

Updated: May 13, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Clinical biomarkers in multiple sclerosis.

John W Rose¹, Noel G Carlson

¹University of Utah , Neurology Service, VASLCHCS, Salt Lake City, UT 84148 , USA.

Expert Opinion on Medical Diagnostics

|March 15, 2013

Summary

New biomarkers for multiple sclerosis (MS) are advancing diagnosis and treatment. These markers aid in understanding disease progression and monitoring therapy effectiveness for better patient outcomes.

Area of Science:

Neurology
Biomarker Discovery

Background:

Intensified search for meaningful biomarkers in multiple sclerosis (MS) over the past five years.
Advances offer potential for new clinical tools in MS diagnosis, co-factor detection, and progression assessment.
Expanding MS therapies necessitate biomarkers for monitoring treatment efficacy.

Purpose of the Study:

To review recent advances in MS biomarkers.
To highlight progress in clinical, genetic, serologic, cerebrospinal fluid, and MRI-based markers.
To identify emerging biomarkers for clinical practice in MS treatment.

Main Methods:

Review of recent scientific literature on MS biomarkers.
Focus on clinical measures, genetic markers, serologic markers, cerebrospinal fluid (CSF) markers, and MRI measures.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: May 13, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Examination of biomarkers associated with emerging MS therapies.

Main Results:

Significant progress in identifying various types of MS biomarkers.
Potential for new biomarkers to emerge in clinical practice.
Highlighting areas of recent progress in biomarker research for MS.

Conclusions:

New MS biomarker discovery enhances understanding of disease pathogenesis.
Biomarkers promise improved diagnostic tools for multiple sclerosis.
Advancements in biomarkers offer potential for refined treatment strategies in MS.